COPENHAGEN, DENMARK / ACCESS Newswire / March 18, 2026 / FluoGuide A/S (STO:FLUO) ("FluoGuide" or the "Company"), a biotech company maximizing surgical outcomes in oncology by lighting up cancer, ...
The U.S. Food and Drug Administration (FDA) has accepted a new drug application for TLX101-Px, an investigational PET imaging agent designed to help distinguish tumor progression ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results